GlassScriptPhysician profile
James R Holfinger
NPI 1417997016
$861.06
in general payments reported to CMS, 2019-2025
17 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $17.46 · 2021: $78.59 · 2022: $60.15 · 2023: $222 · 2024: $201 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $135.47 | 2019-2025 | Citrefix, 7 X 23mm Citrelock Implant, Salvation |
| Smith+Nephew, INC. | $131.02 | 2022-2025 | Grafix Pl |
| Horizon Therapeutics Plc | $123.50 | 2019 | |
| Treace Medical Concepts, INC. | $80.83 | 2023-2024 | |
| Amgen INC. | $54.88 | 2024 | Krystexxa |
| Nevro Corp. | $46.36 | 2023 | Senza |
| Paragon 28, INC. | $44.61 | 2022-2024 | Mtp |
| Aroa Biosurgery Incorporated | $38.80 | 2024 | |
| Bioventus LLC | $36.71 | 2020-2021 | |
| Polynovo North America LLC | $33.91 | 2025 | Novosorb Btm |
| Abbott Laboratories | $32.91 | 2021 | |
| Kerecis Limited | $21.56 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $20.87 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Orthofix Medical, INC. | $17.80 | 2025 | Physio-Stim |
| Seagen INC. | $15.40 | 2023 | Tukysa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $13.80 | 2021 | |
| Next Science LLC | $12.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Holfinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.